Past Meeting: Lindau, Germany 2002

 

Main Program Oral Presentations


  • Which ophthalmic preservatives are safe?
  • New Tools in drug discovery and toxicity testing
  • Applicability of an organotypic retinal culture as a drug testing system
  • Organization and Function of Dopaminergic Neurons in Mammalian Retinas
  • Vision in Parkinsons Disease
  • Pramipexole-related retinal degeneration restricted to the albino rat
  • Retinal Safety of Long-Term Oral Treatment with Pramipexole in Patients with Parkinsons Disease
  • Detailed functional findings from a cross sectional study of parkinsonian patients
  • No signicant retinal changes during long term treatment of Parkinson disease with ropinirole
  • Therapeutic vaccination for glaucoma
  • The Scientic Basis for Alpha2 Adrener gic Retinal Neuroprotection
  • The BRAION Multicenter StudyNAION as a model to test neuroprotective capacities
  • Pharmacokinetic aspects of intravitreally applied neuroprotective agents in small animal models
  • Modulation of kynurenic acid (KYNA) content in the retina in response to retinal ganglion cell damage
  • A Model for Carotenoid Metabolism in the Human Retina
  • Dietary effects of carotenoids and essential fatty acids on monkey retinas
  • Accumulation and Metabolism of Carotenoid Isomers in the Retina
  • Ocular safety of viagra (silde nafil citrate)
  • The inverse dose-rate effect and its implications in ocular radiation risk to humans
  • Retinal degeneration induced by visible light: Signaling pathways and mechanisms of photoreceptor protection
  • Substances of the humic acid type - what makes them interesting for medical use?
  • UV-B protective effect of natural humic acids and their synthetic analogs
  • Investigations into the mechanism of uv-b protective effects of synthetic humic acid analogs
  • Intra and extaraocular temperature changes in rabbits exposed to either infrared rays or microwaves
  • Changes of kynurenic acid content in the rat and chicken retina during ontogeny
  • Growth factors in aqueous humor modulate mRNA expression of decorin and biglycan by trabecular cells
  • Trabecular cells exposed to growth factors in secondary aqueous humor increase mRNA expression of fibronectin and decrease mRNA expression of MMP-3
  • Modied allomaterial for iridoprosthesis
  • Non-systemic delivery to the brain of ocular therapeutics: the neuro-ocular tissue distribution of topical brimonidine
  • Do all photopic ash electroretinograms include a post-retinal i-wave?
  • Apoptotic cell death in retinal ganglion cells of DBA/2J mice
  • Importance of Baseline for Electrophysiology Assessment of Drug Induced Changes in Children with Seizures
  • Ocular safety of lutein and zeaxanthin in a long-term study in cynomolgous monkeys
  • In vitrocornea model - a new opportunity I organ culture and a test system replacing in vivo experiments
  • No smoking? Effects of nicotine on spontaneous pupillary oscillations
  • Growth of corneal epithelial cells in vitro and the cellular effects of some clinically relevant eye medication
  • Fluocinolone Acetonide Implant Technology and First Experiences in Uveitis
  • Evidence for pro-oxidative effects of ss carotene
  • ERG Findings in Patients on Hydroxy chloroquine Treatment
  • Drug - side effects in long term antimalarial prophylaxis
  • New recommendations for screening for hydroxychloroquine and chloroquine retinopathy by the american academy of ophthalmology
  • Ocular autonomic involvement in botulism
  • No smoking Effects of nicotine on spontaneous pupillary oscillations
  • Retinal changes of six women accidentally poisoned elsewhere with Flukiver,antihelmintic drug for cattle
  • What drugs are currently of greatest interest to the practicing ophthalmologist?
  • Nutritional factors and their interaction with experimental cataract development - a review
  • Vitamin E deciency delays Cataract On set in a Rat Model for Bone Marrow Transplantation
  • Biomechanical properties of a new accommodative intraocular lens
  • Effects of PDE inhibitors on the retina: Electrophysiological investigations
  • Recommendation for electrophysiology in clinical trials
  • Amiodarone and optic neuropathy
  • Study of the safety of synthetic peptide epitalon
  • Ocular examinations in two alternative non-rodent species used in drug safety studies (minipigs and marmosets)
  • Characteristics of drug-induced retinal degeneration in cats
  • Evaluation of historical back ground findings in the fun dus of cynomolgus monkeys
  • Laser-Induced CNV in Drug Development Experiences with the Monkey Model
  • A new animal model of induced ocular hyperpressure using the minipig: eye fundus images, electroretinography and Scanning Laser Ophthalmosocope (SLO) angiography
  • Ocular Disorders and Corticosteroids
  • Pharmakokinetics of topical corticosteroids
  • Fluocinolone Acetonide Implant in the Treatment of Diabetic Macular Edema: The American Study
  • Treatment of the traumatic optic neuropathy with high dose corticosteroids, experimental study